Center-Authored Papers

Filters: Author is Self, Steven G  [Clear All Filters]
2008
Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, Self SG, Corey L.  2008.  Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa.. PloS one. 3(5):e2230. Abstract
Sampson JN, Self SG.  2008.  Identifying trait clusters by linkage profiles: application in genetical genomics.. Bioinformatics (Oxford, England). 24(7):958-64. Abstract
Gasper-Smith N, Crossman DM, Whitesides JF, Mensali N, Ottinger JS, Plonk SG, Moody AM, Ferrari G, Weinhold KJ, Miller SE et al..  2008.  Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.. Journal of virology. 82(15):7700-10. Abstract
Morgan C, Marthas M, Miller C, Duerr A, Cheng-Mayer C, Desrosiers R, Flores J, Haigwood N, Hu S-lok, Johnson PR et al..  2008.  The use of nonhuman primate models in HIV vaccine development.. PLoS medicine. 5(8):e173.
Tomaras GD, Yates NL, Liu P, Qin L, Fouda GG, Chavez LL, Decamp AC, Parks RJ, Ashley VC, Lucas JT et al..  2008.  Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.. Journal of virology. 82(24):12449-63. Abstract
Jaspan HB, Cunningham CK, Tucker TJP, Wright PF, Self SG, Sheets RL, Rogers AS, Bekker L-G, Wilson CM, Duerr A et al..  2008.  Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroads.. Journal of acquired immune deficiency syndromes (1999). 47(1):86-92. Abstract
Boily M-C, Abu-Raddad L, Desai K, Masse B, Self SG, Anderson R.  2008.  Measuring the public-health impact of candidate HIV vaccines as part of the licensing process.. The Lancet infectious diseases. 8(3):200-7. Abstract
Li F, McKenney DM, Malhotra U, Crimi C, Nolin J, Corey L, McElrath MJ, Newman MJ, Self SG.  2008.  Towards prediction of degenerate CTL epitope recognition.. Human vaccines. 4(2):115-21. Abstract
McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, Defawe OD, Carter DK, Hural J, Akondy R et al..  2008.  HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.. Lancet. 372(9653):1894-905. Abstract
Gilbert PB, Qin L, Self SG.  2008.  Evaluating a surrogate endpoint at three levels, with application to vaccine development.. Statistics in medicine. 27(23):4758-78. Abstract
Shulman N, Bellew M, Snelling G, Carter D, Huang Y, Li H, Self SG, McElrath MJ, De Rosa SC.  2008.  Development of an automated analysis system for data from flow cytometric intracellular cytokine staining assays from clinical vaccine trials.. Cytometry. Part A : the journal of the International Society for Analytical Cytology. 73(9):847-56. Abstract
2009
Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J, Lebedeva M, DeCamp A, Li D, Grove D et al..  2009.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.. Journal of virology. 83(8):3719-33. Abstract
Hudgens MG, Gilbert PB, Mascola JR, Wu C-D, Barouch DH, Self SG.  2009.  Power to detect the effects of HIV vaccination in repeated low-dose challenge experiments.. The Journal of infectious diseases. 200(4):609-13. Abstract
Kollmann TR, Crabtree J, Rein-Weston A, Blimkie D, Thommai F, Wang XY, Lavoie PM, Furlong J, Fortuno ES, Hajjar AM et al..  2009.  Neonatal innate TLR-mediated responses are distinct from those of adults.. Journal of immunology (Baltimore, Md. : 1950). 183(11):7150-60. Abstract
Huang Y, Gilbert PB, Montefiori DC, Self SG.  2009.  Simultaneous Evaluation of the Magnitude and Breadth of a Left and Right Censored Multivariate Response, with Application to HIV Vaccine Development.. Statistics in biopharmaceutical research. 1(1):81-91. Abstract
Gilbert PB, Qin L, Self SG.  2009.  Response to Andrew Dunning's comment on 'evaluating a surrogate endpoint at three levels, with application to vaccine development'.. Statistics in medicine. 28(4):716-9.
Sather ND, Armann J, Ching LK, Mavrantoni A, Sellhorn G, Caldwell Z, Yu X, Wood B, Self SG, Kalams S et al..  2009.  Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection.. Journal of virology. 83(2):757-69. Abstract
Barouch DH, Liu J, Lynch DM, O'Brien KL, La Porte A, Simmons NL, Riggs AM, Clark S, Abbink P, Montefiori DC et al..  2009.  Protective efficacy of a single immunization of a chimeric adenovirus vector-based vaccine against simian immunodeficiency virus challenge in rhesus monkeys.. Journal of virology. 83(18):9584-90. Abstract
2010
Hioe CE, Wrin T, Seaman MS, Yu X, Wood B, Self SG, Williams C, Gorny MK, Zolla-Pazner S.  2010.  Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes.. PloS one. 5(4):e10254. Abstract
Gill DK, Huang Y, Levine GL, Sambor A, Carter DK, Sato A, Kopycinski J, Hayes P, Hahn B, Birungi J et al..  2010.  Equivalence of ELISpot assays demonstrated between major HIV network laboratories.. PloS one. 5(12):e14330. Abstract
Corbett NP, Blimkie D, Ho KC, Cai B, Sutherland DP, Kallos A, Crabtree J, Rein-Weston A, Lavoie PM, Turvey SE et al..  2010.  Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells.. PloS one. 5(11):e15041. Abstract
Gilbert PB, Wang M, Wrin T, Petropoulos C, Gurwith M, Sinangil F, D'Souza P, Rodriguez-Chavez IR, DeCamp A, Giganti M et al..  2010.  Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine.. The Journal of infectious diseases. 202(4):595-605. Abstract
Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, Giri A, Coffey RT, Harris L, Wood B, Daniels MG et al..  2010.  Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.. Journal of virology. 84(3):1439-52. Abstract
Ribeiro RM, Qin L, Chavez LL, Li D, Self SG, Perelson AS.  2010.  Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection.. Journal of virology. 84(12):6096-102. Abstract
2011
Nicholson O, Dicandilo F, Kublin J, Sun X, Quirk E, Miller M, Gray G, Pape J, Robertson MN, Mehrotra DV et al..  2011.  Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.. AIDS research and human retroviruses. 27(5):557-567. Abstract